Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Withdrawn 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3NIH 3NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3

Conditions

Uterine Cervical Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Neuroblastoma 5Medulloblastoma 5Carcinoma 4Mouth Neoplasms 3Laryngeal Neoplasms 3Hypopharyngeal Neoplasms 3Ganglioneuroblastoma 3Vulvar Neoplasms 2Stomach Neoplasms 2Oropharyngeal Neoplasms 2Gallbladder Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Vomiting 1Urinary Bladder Neoplasms 1Teratoma 1Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Sertoli-Leydig Cell Tumor 1Rhabdoid Tumor 1Recurrent Uterine Corpus Carcinoma 1Papillomavirus Infections 1Ovarian gynandroblastoma 1Ovarian Neoplasms 1Osteosarcoma 1Neoplasms, Germ Cell and Embryonal 1Neoplasm Metastasis 1Nausea 1Lymphoid Interstitial Pneumonia 1

Interventions

Platinum 3Cisplatin 31,2-diaminocyclohexaneplatinum II citrate 3Taxes 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Magnetic Resonance Spectroscopy 2Carboplatin 2sargramostim 1pembrolizumab 1dehydroftorafur 1X-Rays 1Specimen Handling 1Radiotherapy, Image-Guided 1Radiation 1Polymerase Chain Reaction 1Pilocarpine 1Paclitaxel 1N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 1Gene Expression Profiling 1Fluorouracil 1Fenretinide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Mouth Neoplasms × Platinum × Clear all
NCT02734537 2026-05-15

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Eastern Cooperative Oncology Group

Phase 2 Recruiting
189 enrolled
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms

NCT05721755 2026-05-05

Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting
290 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT06084845 2024-07-25

Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck Cancer

Eastern Cooperative Oncology Group

Phase 2 Withdrawn
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡